**Tevogen Bio Holdings Inc. Receives Nasdaq Non-Compliance Notice** Tevogen Bio Holdings Inc. announced that it has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the Nasdaq's minimum bid price requirement of $1.00 per share. The notice, received on September 23, 2025, was issued after the company's common stock traded below $1.00 for 30 consecutive business days. Tevogen Bio has 180 calendar days, until March 23, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The company may be eligible for an additional 180-day compliance period if certain conditions are met. Tevogen Bio stated that it is monitoring the situation and evaluating options, but there is no assurance it will regain compliance or maintain its Nasdaq listing. The notice does not immediately affect the company's listing or trading on the Nasdaq Global Market.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-015784), on September 26, 2025, and is solely responsible for the information contained therein.
Comments